Toni_20 Active member May 29, 2026 #21 Novo reaching out to patients directly is the defensive play before the patent cliff - retention outreach is cheaper than competing on price later.
Novo reaching out to patients directly is the defensive play before the patent cliff - retention outreach is cheaper than competing on price later.